Article

Cross Species Genomic Analysis Identifies a Mouse Model as Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma

Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina, United States of America.
PLoS ONE (Impact Factor: 3.53). 11/2009; 4(11):e8075. DOI: 10.1371/journal.pone.0008075
Source: PubMed

ABSTRACT Undifferentiated pleomorphic sarcoma/Malignant Fibrous Histiocytoma (MFH) is one of the most common subtypes of human soft tissue sarcoma. Using cross species genomic analysis, we define a geneset from the LSL-Kras(G12D); Trp53(Flox/Flox) mouse model of soft tissue sarcoma that is highly enriched in human MFH. With this mouse geneset as a filter, we identify expression of the RAS target FOXM1 in human MFH. Expression of Foxm1 is elevated in mouse sarcomas that metastasize to the lung and tissue microarray analysis of human MFH correlates overexpression of FOXM1 with metastasis. These results suggest that genomic alterations present in human MFH are conserved in the LSL-Kras(G12D); p53(Flox/Flox) mouse model of soft tissue sarcoma and demonstrate the utility of this pre-clinical model.

Download full-text

Full-text

Available from: Brian E Brigman, Jul 30, 2015
0 Followers
 · 
133 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The concept of Triclusters has been investigated recently in the context of two relational datasets that share labels along one of the dimensions. By simultaneously processing two datasets to unveil triclusters, new useful knowledge and insights can be obtained. However, some recently reported methods are either closely linked to specific problems or constrain datasets to have some specific distributions. Algorithms for generating triclusters whose cell-values demonstrate simple well known statistical properties, such as upper bounds on standard deviations, are needed for many applications. In this paper we present a 3-Clustering algorithm that searches for meaningful combinations of biclusters in two related datasets. The algorithm can handle situations involving: (i) datasets in which a few data objects may be present in only one dataset and not in both datasets, (ii) the two datasets may have different numbers of objects and/or attributes, and (iii) the cell-value distributions in two datasets may be different. In our formulation the cell-values of each selected tricluster, formed by two independent biclusters, are such that the standard deviations in each bicluster obeys an upper bound and the sets of objects in the two biclusters overlap to the maximum possible extent. We present validation of our algorithm by presenting the properties of the 3-Clusters discovered from a synthetic dataset and from a real world cross-species genomic dataset. The results of our algorithm unveil interesting insights for the cross-species genomic domain.
    ICDM 2010, The 10th IEEE International Conference on Data Mining, Sydney, Australia, 14-17 December 2010; 01/2010
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Soft-tissue sarcomas (STSs) are rare mesenchymal tumors that arise from muscle, fat and connective tissue. Currently, over 75 subtypes of STS are recognized. The rarity and heterogeneity of patient samples complicate clinical investigations into sarcoma biology. Model organisms might provide traction to our understanding and treatment of the disease. Over the past 10 years, many successful animal models of STS have been developed, primarily genetically engineered mice and zebrafish. These models are useful for studying the relevant oncogenes, signaling pathways and other cell changes involved in generating STSs. Recently, these model systems have become preclinical platforms in which to evaluate new drugs and treatment regimens. Thus, animal models are useful surrogates for understanding STS disease susceptibility and pathogenesis as well as for testing potential therapeutic strategies.
    Disease Models and Mechanisms 09/2010; 3(9-10):557-66. DOI:10.1242/dmm.005223 · 5.54 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The laboratory mouse has been used for many decades as a model system for radiation research. Recent advances in genetic engineering now allow scientists to delete genes in specific cell types at different stages of development. The ability to manipulate genes in the mouse with spatial and temporal control opens new opportunities to investigate the role of genes in regulating the response of normal tissues and tumors to radiation. Currently, we are using the Cre-loxP system to delete genes, such as p53, in a cell-type specific manner in mice to study mechanisms of acute radiation injury and late effects of radiation. Our results demonstrate that p53 is required in the gastrointestinal (GI) epithelium to prevent radiation-induced GI syndrome and in endothelial and/or hematopoietic cells to prevent late effects of radiation. We have also used these genetic tools to generate primary tumors in mice to study tumor response to radiation therapy. These advances in genetic engineering provide a powerful model system to dissect both the mechanisms of normal tissue injury after irradiation and the mechanisms by which radiation cures cancer.
    Radiation Research 09/2011; 176(3):275-9. DOI:10.2307/41318191 · 2.45 Impact Factor
Show more